TransMedics Group, Inc. (TMDX)

US — Healthcare Sector
Peers: CLPT  DMTKQ  INSP  OM 

Automate Your Wheel Strategy on TMDX

With Tiblio's Option Bot, you can configure your own wheel strategy including TMDX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol TMDX
  • Rev/Share 15.6663
  • Book/Share 9.3799
  • PB 12.6835
  • Debt/Equity 1.4439
  • CurrentRatio 9.8575
  • ROIC 0.0916

 

  • MktCap 4025207186.0
  • FreeCF/Share 0.5117
  • PFCF 231.9737
  • PE 56.3008
  • Debt/Assets 0.5158
  • DivYield 0
  • ROE 0.2802

 

  • Rating C+
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 1
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Downgrade TMDX JP Morgan Overweight Neutral $116 $75 Dec. 17, 2024
Initiation TMDX Robert W. Baird -- Outperform -- $200 Sept. 24, 2024
Initiation TMDX Needham -- Buy -- $208 Aug. 21, 2024

News

Shareholders of TransMedics Group, Inc. Should Contact Levi & Korsinsky Before April 15, 2025 to Discuss Your Rights - TMDX
TMDX
Published: March 21, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 21, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=137866&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Shareholders of TransMedics Group, Inc. Should Contact Levi & Korsinsky Before April 15, 2025 to Discuss Your Rights - TMDX
TransMedics Group (TMDX) Plunges Amidst Allegations of Fraud, Organ Trafficking – Hagens Berman
TMDX
Published: March 21, 2025 by: GlobeNewsWire
Sentiment: Neutral

SAN FRANCISCO, March 21, 2025 (GLOBE NEWSWIRE) -- A class-action lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX), a medical technology company specializing in organ transplant therapy, alleging that the company and certain executives engaged in fraudulent practices and concealed safety issues. The suit, captioned Jewik v. TransMedics Group, Inc., No. 25-cv-10385 (D. Mass.), represents investors who purchased or acquired TransMedics securities between February 28, 2023, and January 10, 2025.

Read More
image for news TransMedics Group (TMDX) Plunges Amidst Allegations of Fraud, Organ Trafficking – Hagens Berman
TMDX LAWSUIT ALERT: Levi & Korsinsky Notifies TransMedics Group, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
TMDX
Published: March 21, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, March 21, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in TransMedics Group, Inc. ("TransMedics" or the "Company") (NASDAQ: TMDX) of a class action securities lawsuit.

Read More
image for news TMDX LAWSUIT ALERT: Levi & Korsinsky Notifies TransMedics Group, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
TransMedics Group, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 15, 2025 to Discuss Your Rights - TMDX
TMDX
Published: March 21, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 21, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=137830&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news TransMedics Group, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 15, 2025 to Discuss Your Rights - TMDX
Faruqi & Faruqi Reminds TransMedics Group Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 15, 2025 - TMDX
TMDX
Published: March 21, 2025 by: PRNewsWire
Sentiment: Neutral

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In TransMedics To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in TransMedics between February 23, 2023 and January 10, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , March 21, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against TransMedics Group, Inc. ("TransMedics" …

Read More
image for news Faruqi & Faruqi Reminds TransMedics Group Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 15, 2025 - TMDX
TransMedics Group, Inc. Class Action: Levi & Korsinsky Reminds TransMedics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 15, 2025 - TMDX
TMDX
Published: March 21, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 21, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=137763&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news TransMedics Group, Inc. Class Action: Levi & Korsinsky Reminds TransMedics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 15, 2025 - TMDX
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in TransMedics Group, Inc of Class Action Lawsuit and Upcoming Deadlines - TMDX
TMDX
Published: March 21, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK CITY, NY / ACCESS Newswire / March 21, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against TransMedics Group, Inc ("TransMedics" or the "Company") (NYSE:TMDX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

Read More
image for news INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in TransMedics Group, Inc of Class Action Lawsuit and Upcoming Deadlines - TMDX
TMDX Investors Have Opportunity to Lead TransMedics Group, Inc. Securities Fraud Lawsuit with the Schall Law Firm
TMDX
Published: March 21, 2025 by: PRNewsWire
Sentiment: Neutral

LOS ANGELES , March 21, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against TransMedics Group, Inc. ("TransMedics" or "the Company") (NASDAQ: TMDX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 28, 2023 and January 10, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before April 15, 2025.

Read More
image for news TMDX Investors Have Opportunity to Lead TransMedics Group, Inc. Securities Fraud Lawsuit with the Schall Law Firm
TransMedics Group, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm for More Information – TMDX
TMDX
Published: March 20, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of TransMedics Group, Inc. (NASDAQ: TMDX).

Read More
image for news TransMedics Group, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm for More Information – TMDX
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 15, 2025 in TransMedics Lawsuit - TMDX
TMDX
Published: March 20, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 20, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=137487&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 15, 2025 in TransMedics Lawsuit - TMDX
Levi & Korsinsky Reminds TransMedics Group, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 15, 2025 - TMDX
TMDX
Published: March 20, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 20, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=137476&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Levi & Korsinsky Reminds TransMedics Group, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 15, 2025 - TMDX
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of TransMedics Group, Inc. (TMDX) Shareholders
TMDX
Published: March 20, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 20, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=137370&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of TransMedics Group, Inc. (TMDX) Shareholders
TMDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that TransMedics Group, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
TMDX
Published: March 20, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 20, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against TransMedics Group, Inc. ("TransMedics" or "the Company") (NASDAQ:TMDX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired TransMedics securities between February 3, 2022 and February 3, 2025, both dates inclusive (the "Class Period").

Read More
image for news TMDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that TransMedics Group, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
The Gross Law Firm Reminds TransMedics Group, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 15, 2025 - TMDX
TMDX
Published: March 20, 2025 by: PRNewsWire
Sentiment: Neutral

NEW YORK , March 20, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of TransMedics Group, Inc. (NASDAQ: TMDX). Shareholders who purchased shares of TMDX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

Read More
image for news The Gross Law Firm Reminds TransMedics Group, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 15, 2025 - TMDX
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of TransMedics Group, Inc.(TMDX) Shareholders
TMDX
Published: March 19, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 19, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=137317&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of TransMedics Group, Inc.(TMDX) Shareholders
TMDX Investors Have Opportunity to Lead TransMedics Group, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
TMDX
Published: March 19, 2025 by: PRNewsWire
Sentiment: Neutral

NEW YORK , March 19, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of TransMedics Group, Inc. (NASDAQ: TMDX) between February 28, 2023 and January 10, 2025, both dates inclusive (the "Class Period"), of the important April 15, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. So what: If you purchased TransMedics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Read More
image for news TMDX Investors Have Opportunity to Lead TransMedics Group, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
Kirby McInerney LLP Reminds TransMedics Group, Inc. (TMDX) Investors of Securities Class Action Lawsuit and Encourages Investors to Contact the Firm
TMDX
Published: March 19, 2025 by: Business Wire
Sentiment: Neutral

NEW YORK--(BUSINESS WIRE)---- $TMDX #CLASSACTIONLAWSUIT--The law firm of Kirby McInerney LLP reminds investors who purchased TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQ:TMDX) securities to contact Thomas W. Elrod of Kirby McInerney LLP by email at [email protected], or fill out the contact form below, to discuss your rights or interests with respect to the securities fraud class action lawsuit against the Company. [LEARN MORE ABOUT THE CLASS ACTION] The lawsuit was filed on behalf of investors wh.

Read More
image for news Kirby McInerney LLP Reminds TransMedics Group, Inc. (TMDX) Investors of Securities Class Action Lawsuit and Encourages Investors to Contact the Firm
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 15, 2025 in TransMedics Lawsuit – TMDX
TMDX
Published: March 19, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 19, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=137286&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 15, 2025 in TransMedics Lawsuit – TMDX
TransMedics Group, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - TMDX
TMDX
Published: March 19, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 19, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=137213&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news TransMedics Group, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - TMDX
Investors who Lost Money on TransMedics Group, Inc. (TMDX) Should Contact Levi & Korsinsky About Pending Class Action - TMDX
TMDX
Published: March 19, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 19, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=137171&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Investors who Lost Money on TransMedics Group, Inc. (TMDX) Should Contact Levi & Korsinsky About Pending Class Action - TMDX
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in TransMedics Group, Inc of Class Action Lawsuit and Upcoming Deadlines - TMDX
TMDX
Published: March 19, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK CITY, NY / ACCESS Newswire / March 19, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against TransMedics Group, Inc ("TransMedics" or the "Company") (NYSE:TMDX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

Read More
image for news INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in TransMedics Group, Inc of Class Action Lawsuit and Upcoming Deadlines - TMDX
Shareholders of TransMedics Group, Inc. Should Contact Levi & Korsinsky Before April 15, 2025 to Discuss Your Rights - TMDX
TMDX
Published: March 18, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 18, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=136912&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Shareholders of TransMedics Group, Inc. Should Contact Levi & Korsinsky Before April 15, 2025 to Discuss Your Rights - TMDX
ROSEN, SKILLED INVESTOR COUNSEL, Encourages TransMedics Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TMDX
TMDX
Published: March 18, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 18, 2025 / Rosen Law Firm: WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of TransMedics Group, Inc. (NASDAQ:TMDX) between February 28, 2023 and January 10, 2025, both dates inclusive (the "Class Period"), of the important April 15, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased TransMedics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Read More
image for news ROSEN, SKILLED INVESTOR COUNSEL, Encourages TransMedics Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TMDX
Shareholders that lost money on TransMedics Group, Inc. (TMDX) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
TMDX
Published: March 18, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 18, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=136899&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Shareholders that lost money on TransMedics Group, Inc. (TMDX) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
Shareholders that Lost Money on TransMedics Group, Inc. (TMDX) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
TMDX
Published: March 18, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 18, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=136887&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Shareholders that Lost Money on TransMedics Group, Inc. (TMDX) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 15, 2025 in TransMedics Lawsuit - TMDX
TMDX
Published: March 17, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 17, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=136667&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 15, 2025 in TransMedics Lawsuit - TMDX
TransMedics Group, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm for More Information – TMDX
TMDX
Published: March 17, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, March 17, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of TransMedics Group, Inc. (NASDAQ: TMDX).

Read More
image for news TransMedics Group, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm for More Information – TMDX
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in TransMedics Group, Inc of Class Action Lawsuit and Upcoming Deadlines - TMDX
TMDX
Published: March 17, 2025 by: PRNewsWire
Sentiment: Neutral

NEW YORK , March 17, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against TransMedics Group, Inc ("TransMedics" or the "Company") (NYSE: TMDX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

Read More
image for news INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in TransMedics Group, Inc of Class Action Lawsuit and Upcoming Deadlines - TMDX
TransMedics Group, Inc. Class Action: Levi & Korsinsky Reminds TransMedics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 15, 2025 – TMDX
TMDX
Published: March 17, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 17, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=136521&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news TransMedics Group, Inc. Class Action: Levi & Korsinsky Reminds TransMedics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 15, 2025 – TMDX
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of TransMedics Group, Inc. (TMDX) Shareholders
TMDX
Published: March 14, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 14, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=136111&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of TransMedics Group, Inc. (TMDX) Shareholders

About TransMedics Group, Inc. (TMDX)

  • IPO Date 2019-05-02
  • Website https://www.transmedics.com
  • Industry Medical - Devices
  • CEO Waleed H. Hassanein
  • Employees 728

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.